跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
左甲状腺素钠片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Levothyroxine Sodium Tablets
Approved
化学药品
Levothyroxine Sodium Tablets
Cipla Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Nov 5, 2024
Approval ID
8eX3UwV4D32
Company
Cipla Ltd.
Type
化学药品
Approval Details
Approval Id
8eX3UwV4D32
Approval Number
国药准字HJ20240127
Generic Name
左甲状腺素钠片
Generic Name En
Levothyroxine Sodium Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
50µg
Reg Date
2024-11-05
Expired Date
2029-11-04
Company Name
Cipla Ltd.
Company Address
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400013, India
Production Company Name
m/s acme generics pvt. ltd.
Production Company Address
Plot No. 115, HPSIDC Industrial Area, Village Davni, P.O. Gurumajra, Tehsil Nalagarh, Distt. Solan,- (H.P.)
Company Detail Path
/organization/cipla-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 5, 2024
Approval ID
8eX3UwV4D32
Type
化学药品
Back to NMPA Approvals